Similar biological medicinal products containing interferon beta

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMA/CHMP/BMWP/652000/2010
Published06/03/2013
Effective from01/09/2013
KeywordsInterferon beta, similar biological medicinal product, biosimilar, comparability, non-clinical studies, clinical studies
DescriptionThis document lays down the non-clinical and clinical requirements for interferon beta (IFN-β) containing medicinal products claiming to be similar to another interferon beta already marketed.


Document history

First version

Current version

Adopted guideline


Overview of comments


Draft guideline


Concept paper

In operation: 01/09/2013–present


Published: 06/03/2013


Published: 19/01/2012


Published: 06/04/2010


Related content


How helpful is this page?

Average rating:

 Based on 1 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
1 ratings
    

Tell us more